Company ProfilePremium

PPK Group Limited

Company Profile Analysis

Ticker: PPK.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
PPK Group Limited - Company showcase

Year Founded & Workforce

1979

PPK Group Limited logo

PPK Group Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

PPK Group Limited Overview

PPK Group is a small-cap Brisbane-based holding company that has reinvented itself several times: from a plastics packaging business (Plaspak, 1979), to a mining equipment manufacturer, to a university-sourced technology incubator built around boron nitride nanomaterials licensed from Deakin University. It is now a capital allocator that holds one controlled operating business — PowerPlus Energy (75.4%), an Australian manufacturer of lithium iron phosphate (LFP) batteries and battery energy storage systems — and two equity-accounted associates: ASX-listed Li-S Energy (39.11%), which develops lithium-sulfur cells for drones and defence, and the merged White Graphene/BNNT nanomaterials business (39.36%). In June 2026, PPK sold its 39.85% stake in Craig International Ballistics for A$27.2m in cash plus up to about A$6.0m in earn-out. This leaves the group with roughly A$27.7m of cash, a A$2.5m on-market buy-back, and a stated plan to buy outright one high-quality Australian operating business as its future cornerstone.


Company's own description (FY26 Annual Report, paraphrased)

The FY26 Directors' Report describes PPK's principal continuing activity as investing capital and expertise in high-potential opportunities. Its current focus is energy storage, safety-related products and nanomaterials. The stated aim is to strengthen each investment and exit it when appropriate. The portfolio during FY26 comprised:

  • energy storage assets: Li-S Energy Limited and PowerPlus Energy Pty Ltd;

  • ballistic protection via Craig International Ballistics Pty Ltd (sold 29 June 2026); and

  • nanomaterials: BNNT Technology Pty Ltd and White Graphene Limited (merged July 2025, deconsolidated November 2025).

PPK also provides finance, IT, legal, cyber security, payroll, capital-raising and transactional shared services to portfolio companies. Those companies pay fees that partially recover PPK's corporate costs. Management fees received fell from A$1.613m in FY25 to A$0.945m in FY26 (FY26 Annual Report).

The FY26 Chair's Report sets out a new phase. The Board wants to become the long-term owner of an outstanding operating business, acquired outright, rather than a serial acquirer or a speculative investor. It says it will be patient and selective, may look beyond energy storage, and is optimistic of concluding a transaction during FY27.

Independent characterisation

Economically, PPK today is a listed holding company with five layers of value:

  1. a cash balance of A$27.7m (consolidated; A$25.7m held directly by PPK at 30 June 2026);

  2. a controlled, near-breakeven manufacturing subsidiary (PPE, FY26 revenue A$27.8m, EBITDA A$1.3m);

  3. a 39.11% stake in a listed pre-revenue battery developer (LIS, about 251 million shares);

  4. a 39.36% stake in an unlisted pre-revenue nanomaterials business (WGL); and

  5. contingent receivables: A$0.5m deferred plus up to about A$6.0m CIB earn-out, and an uncapped AMAG earn-out.

Corporate overhead of A$3.6m underlying in FY26 is the main recurring cash drain at the parent level.

Revenue model and mix

Revenue streamModelFY26 relevance
Battery and BESS product sales (PPE)Product sales through distributors and installers; volume rebates and rights of return create variable consideration (FY24 Annual Report Note 2.8)~100% of consolidated revenue (A$28.709m group vs A$27.764m PPE sales)
Shared-services/management feesFee-for-service from associates and subsidiaries (eliminated on consolidation for subsidiaries)A$0.945m received from associates in FY26
Equity-accounted incomeShare of associates' profit/loss (CIB, LIS, WGL)A$0.211m net share of profit in FY26
Dividends/distributionsCash dividends from associates (CIB)A$2.397m from CIB (July 2025)
RealisationsGains on disposal/deconsolidationA$18.308m CIB gain; A$6.937m WGL deconsolidation gain
Licensing / subscriptionNone disclosed—

Product vs service mix: consolidated revenue is almost entirely product revenue from PPE. Service revenue is immaterial and largely intra-group.

Value chain position

PPE is a mid-stream assembler and integrator. It sources LFP cells (the Whispr-7 uses CATL cells per the FY25 Annual Report), designs modules, and assembles and tests them in Melbourne. It then integrates complete BESS solutions and sells through an installer and distributor network. LIS sits upstream, as a cell-chemistry and lithium-metal-foil developer. WGL/BNNT is further upstream again, producing advanced additive materials.

Customer types and end-markets

BusinessCustomer typesEnd-markets
PPEElectrical installers, distributors, C&I end users, farms, utilities, telcos, eco-tourism, mine sites, residential households (since FY25 via Cheaper Home Batteries Program)Off-grid, fringe-of-grid and on-grid stationary storage in Australia; residential, agriculture, utilities, tourism, telecommunications, commercial (FY26 Annual Report)
LIS (associate)Drone and aerospace OEMs, defence agencies (US Army DEVCOM C5ISR Center delivery Aug 2026), maritime (MSubs), V-TOL Aerospace, Praetorian AeronauticsDrones, defence, electric aviation; lithium foil for battery makers
WGL/BNNT (associate)Coatings, lubricants, composites, metal/polymer developers; luxury watchmaker evaluation (FY25); international distributors (e.g. Filgen)Advanced materials R&D
CIB (divested Jun-2026)Australian Defence Force, police and law enforcement, naval shipbuilding (Hunter Class Frigate transparent armour)Personal and platform ballistic protection

Strategy

Stated strategy (FY26 Annual Report themes, paraphrased)

  1. Disciplined capital allocation is the Board's foremost responsibility; every decision is tested against long-term value creation.

  2. Acquire a cornerstone operating business: a high-quality, Australian-based business that PPK can acquire outright, with capable management and attractive long-term economics. Energy storage is a natural focus, but opportunities beyond it are being considered. The Board wants to be patient and selective, is not seeking to be a serial acquirer, and hopes to conclude a deal in FY27.

  3. Return a portion of realised value: an on-market buy-back of up to A$2.5m, about 10% of net CIB proceeds, chosen in preference to a final or special dividend because the shares trade at a material discount to underlying value.

  4. Support existing portfolio companies: retained cash gives flexibility to fund PPE scale-up and to support LIS and WGL.

  5. Simplify the group: the deconsolidations of LIS (October 2024) and WGL (November 2025) are explicitly framed as improving the clarity of the financial statements and reducing related-party conflicts.

The earlier (FY24) stated mandate was to build a portfolio of growth-stage companies with sovereign Australian manufacturing capability, and to be opportunistic in Australian battery supply-chain consolidation. The FY26 pivot is a material strategic shift: from a multi-asset incubator toward a holding company anchored by one wholly owned operating business.

Initiatives in the last 24 months

InitiativeDateDescriptionTargets / status
LIS deconsolidation and in-specie dividendOct 20245.71c fully franked in-specie distribution of LIS sharesCompleted
AMAG exitOct 2024Sale to TransoftCompleted; earn-out pending
Board renewalJul–Dec 2024New Chair; Francis appointedCompleted
PPE product roadmap (Eco4847P, Whispr-7, LiNET4835, LiFe4851, Escape 215)FY25–FY26Entry into the residential market via the Cheaper Home Batteries ProgramProducts launched
PPE convertible note facilityAug 2024A$2m facility (PPK A$1m; Molloy entities A$1m) at 10%A$1.6m drawn at 30 June 2025
Nanomaterials mergerJul 2025WGL and BNNT combinedCompleted
WGL deconsolidationNov 202522.5m WGL shares sold to a third partyCompleted
PPE stake increase to 75.4%Feb 2026Settlement of matters with a PPE founder-linked entityCompleted
PPE ARENA manufacturing projectApr 2026A$6.7m project, A$2.3m grant; up to 150 MWh per yearSupplier selection under way
CIB divestmentApr–Jun 2026Sale to Mehler; A$27.2m cashCompleted
On-market buy-backAug 2026Up to A$2.5m over FY27Commenced 31 August 2026
Cornerstone acquisition searchFY27Search for an outright acquisitionIn progress; update promised at the 24 November 2026 AGM
Cyber programFY25–FY26Security operations centre (SOC) monitoring, Essential Eight alignment, data loss prevention (DLP) and user behaviour analytics (UEBA), phishing trainingOngoing
Cost programFY25Salary freeze for CEO and CFO in FY25; PPE operational cost cutsCorporate underlying cost fell from A$6.5m (FY24) to A$3.6m (FY26)

Medium-term financial targets and guidance

PPK provides no quantitative revenue, earnings or margin guidance. The only quantified forward markers are:

  • the buy-back of up to A$2.5m over FY27;

  • the CIB earn-out of up to about A$6.0m, determined in H1 FY28;

  • PPE's ARENA project target of 150 MWh per year of capacity over about two years; and

  • LIS's Phase 4 feasibility pathway toward up to 1 GWh per year.

Products & Services

Energy Storage — PowerPlus Energy (controlled, 75.4%)

ProductDescription / capabilities (as disclosed)Target customerLaunch / statusPricing model
LiFe4838PRack-mounted modular LFP battery; Clean Energy Council (CEC) certified, opening wider market accessInstallers, C&I, off-gridCEC approval noted in FY23 Annual ReportNot disclosed (distributor/installer pricing)
Eco4847PRack-mounted LFP battery in the same compact 2RU format, with 17.5% more capacity than its predecessor; CEC accredited late FY25 and eligible for the Cheaper Home Batteries ProgramResidential and C&IReleased FY25—
LiFe4851Rack-mounted battery (new/refreshed offering)C&I, residentialFY26—
LiNET4835Rack-mounted variant co-developed with RFI Technology Solutions to replace ageing lead-acid back-up powerUtilities, telecommunicationsFY25—
Whispr-7 (Whispr residential system)All-in-one residential system using CATL cells and a silent-running inverter; CEC approved; developed with Redx Technologies Australia; operated via PPE Whispr Division Pty Ltd (incorporated 26 May 2025)Residential households (CHBP)FY25 launch; early traction FY26—
Escape Series BESS (incl. Escape 215)Easy-to-install BESS adapted to Australian climates; Escape 215 is a larger (215 kWh-class) C&I systemFarms, eco-tourism, mines, commercialEscape series in FY24; Escape 215 in FY26—
Containerised stand-alone power systemsContainerised SAPS for remote and mining applications (e.g. a WA mine-site wireless mesh network)Mining, remote infrastructureFY24 projectsProject-based
Installer training (CPD)Accredited installer training awarding Continuing Professional Development pointsInstallersFY24—

Notable installations (FY24 Annual Report): Louth Island (SA, eco-tourism); a major WA mine site; the McNeil Dairy Project for Willows Pastoral (Vic). PPE attained ISO 9001 certification in FY24.

Manufacturing capacity project: a A$6.7m project, supported by a A$2.3m ARENA Battery Breakthrough Initiative grant (April 2026), to expand and semi-automate module manufacturing in Melbourne. The target is up to 150 MWh of modules per year, roughly a three-fold increase over two years (FY26 Annual Report).

Advanced Batteries — Li-S Energy (associate, 39.11%; ASX-listed)

Product / capabilityDescriptionTarget customerStatus
Lithium-sulfur pouch cells (10Ah commercial format)456 Wh/kg post-formation energy density on a commercial-sized 10Ah Li-S cell (FY25)Drones, defence, electric aviationPrototype/sample deliveries; first US Government delivery August 2026
Power Cell architecture2C continuous discharge on a commercial 10Ah cell — about 10 times the power of a typical high-energy-density Li-S cell (FY26)Drone, defence, mission-criticalDevelopment/validation
Lithium-metal cellsLithium-metal anodes protected by Li-nanomesh to reduce dendritesAviation, defenceDevelopment
Small-format cells (Phase 3S line)Smaller-format cell line in the dry roomSmaller devicesCommissioned FY25
Battery packs and proprietary BMSFirst packs delivered to V-TOL Aerospace under the EATP grant; BMS tailored to Li-S chemistryDrone OEMsFirst deliveries FY26
Lithium metal foilDescribed as Australia's first dedicated lithium-metal-foil production capability (Geelong); ISO 9001:2015 certified; first commercial sale FY26Battery manufacturers / researchersEarly commercial
Phase 3 facilityA$10m facility; described as Australia's largest pouch-cell manufacturing facility; Battery Test Centre (drop, crush, nail penetration, altitude, thermal)InternalOpened 9 August 2024
Phase 4 scale-up studyA$7.8m ARENA Advancing Renewables Program grant for a feasibility study toward up to 1 GWh per year; Hatch appointed for FEL-1—Feasibility (first A$1.9m tranche received March 2026 quarter)

Regulatory milestones: AUKUS accreditation for dual-use Li-S cell exports to the US and UK without permits (FY25); approvals to airfreight prototype cells internationally (FY26). LIS also held an investment in US-based Zeta Energy (FY22 Annual Report, which notes foreign-exchange movements on that investment).

Nanomaterials — White Graphene Ltd / BNNT Technology (associate, 39.36%)

ProductDescriptionTarget customerStatus
White graphene (boron nitride nanosheets, BNNS)2D boron nitride; FY22 Annual Report describes it as 138 times stronger than steel, four times lighter, three times more thermally conductive than copper, corrosion resistant, hydrogen-impermeable, radiation-shielding. Production exceeds 20 kg per day after optimisation (FY25)Coatings, lubricants, composites, paints, luxury watch composites, LIS battery chemistriesEvaluation and validation stage; no material revenue forecast for FY26
Boron nitride nanotubes (BNNT)Nanoscale reinforcement; FY22 targeted capacity of about 500 kg per year at more than 95% purity; company believes it is the lowest-cost BNNT producer globallyResearch buyers (typically orders under 10 g), LIS, space agency samplesProduction capability reduced; limited market demand
BNNT-XBNNT derivative, lab-scale process at Deakin GeelongPartnersNot progressed beyond lab scale (FY25)
RegulatoryAICIS approval under the Industrial Chemicals Act 2019 covering white graphene and BNNT; independent toxicity tests found no acute toxicity concerns—Approved FY25

Discontinued, divested or halted lines (for completeness)

LineDescriptionOutcome
Craig International BallisticsBody armour; opaque and transparent armour for vehicles, aircraft and vessels; Hunter Class Frigate transparent armour and wiper systems; a A$30m ADF body-armour order (FY24); the southern hemisphere's largest ballistic-industry hydraulic press (FY25)Sold 29 June 2026 to Mehler (Germany)
AMAG (Advanced Mobility Analytics Group)AI road-safety SaaS (SMART Survey, Operations, Safety)Sold October 2024 to Transoft Solutions
Precious Metals (BNNT in gold/silver/copper)Metal matrix composites (45% interest)Gold research did not show the expected benefits (FY25)
Strategic AlloysJV with Amaero International (ASX: 3DA) for BNNT in aluminium and titanium alloys (45%)No commercial outcome disclosed
3D Dental TechnologyBNNT in zirconia and lithium disilicate dental ceramics (45%)Halted FY22; A$0.356m written off
Ballistic GlassBNNT in bullet-resistant glass and body-armour ceramics (40%)Not progressed (FY22 review)
Survivon / Mask InnovationsCopper-coated antiviral masksSurvivon exited August 2022; Mask Innovations' later status not disclosed
PPK Mining EquipmentMining equipment manufacturingDemerged June 2022
Plaspak packagingPlastic packagingLegacy business

Financial Narrative

Basis of preparation note. PPK has re-presented comparatives almost every year because of discontinued operations (mining FY22; LIS FY25; WGL FY26). Each year column below uses the latest available presentation of that year:

  • FY22: FY22 Annual Report (continuing operations; excludes A$37.871m of mining revenue).

  • FY23: FY24 Annual Report.

  • FY24: FY25 Annual Report (re-presented for the LIS deconsolidation).

  • FY25: FY26 Annual Report (re-presented for the WGL deconsolidation).

  • FY26: FY26 Annual Report.

All figures are A$k unless noted.

Income statement

EBITDA and operating income. PPK does not report group EBITDA or an operating income subtotal; both are not publicly disclosed. The only disclosed EBITDA is PPE's FY26 EBITDA of A$1.3m (non-IFRS).

Margins and growth

The calculations are derived from the table above.

  • Revenue CAGR FY23–FY26 (three years) is about 65.3%, distorted by PPE joining in May 2023.

  • Revenue CAGR FY24–FY26 (two years, the first full-year PPE base) is about 0.9%.

  • FY23 gross margin covers only two months of PPE plus minor revenue and is not comparable.

Commentary. Statutory results are dominated by non-operating items, and should be read through the underlying line:

FY22: an A$11.6m BNNT remeasurement gain.

FY25: an A$22.4m LIS impairment, an A$3.2m AMAG impairment and an A$12.2m LIS deconsolidation gain.

FY26: an A$18.3m CIB gain, an A$6.9m WGL deconsolidation gain and an A$6.9m LIS impairment reversal.

On the underlying line the trajectory is unambiguously improving: losses narrowed from A$(15.9)m in FY24 to A$(9.5)m in FY25 and A$(4.0)m in FY26. The drivers are deconsolidation of cash-burning R&D entities, PPE's turnaround to small profitability, and a A$1.7m reduction in corporate underlying cost over two years.

The FY26 statutory profit of A$19.2m is non-recurring. Excluding the CIB gain (after tax A$13.7m), the WGL gain (after tax A$6.2m) and the LIS reversal (after tax A$5.1m), the attributable result would be a loss of roughly A$5.9m. This is an arithmetic illustration only, not a company-disclosed figure.

FY27 will lose the CIB equity-accounted contribution (A$2.8m underlying in FY26, A$4.7m in FY25). That removes the group's only consistently profitable asset from the earnings base.

Balance sheet

Sources: FY22, FY24, FY25 and FY26 Annual Reports. FY23 parent cash is from the FY24 Annual Report. FY22 NTA per share is "from continuing operations". NTA methodology changed in FY25/FY26 to also exclude intangibles and deferred tax. The adjusted (non-IFRS) NTA, which adds back the LIS impairment, was 59.3c in FY25 and 64.7c in FY26.

Commentary. The FY22–FY24 balance sheet was flattered by cash sitting inside LIS from its A$34m IPO — only A$4–5m was held by the parent. Deconsolidation in October 2024 removed A$19.3m of LIS cash and about A$39m of intangibles. By 30 June 2025 the group had net current liabilities of A$2.6m and only A$3.6m of parent cash, and the FY25 accounts carried an explicit going-concern discussion. The CIB sale transformed this: parent cash rose to A$25.7m, working capital returned to A$19.4m, and borrowings fell after a A$2.0m loan secured over part of the CIB stake was repaid.

Remaining debt. Residual borrowings of about A$3.8m are mainly PPE-level:

  • external convertible notes at 10% interest, maturing August 2027, of which A$0.8m is held by Glenn Molloy-related entities; and

  • a loan from PPE minority shareholder Altus Construction, extended to 31 August 2026.

The status of the Altus loan after that date is not disclosed in the materials reviewed.

Off-balance-sheet value. Not recognised:

  • the CIB earn-out of up to about A$6.0m, to be determined in H1 FY28;

  • the AMAG uncapped earn-out; and

  • any premium for strategic control of the LIS block.

Cash flow

Notes:

  • The FY26 cash flow statement was only partially captured in the source excerpt reviewed: receipts from customers were A$33.170m and payments to suppliers and employees A$(37.242)m.

  • CIB sale proceeds of A$27.2m were received on 30 June 2026 and fall in investing activities.

  • Employee share trust purchases of 120,507 shares at A$0.33 in May 2026 are not material.

  • FY22 in-specie figure is the PPKMEG demerger dividend; the 15.11c capital return totalled A$13.49m.

  • The FY24 buy-back was a minimum holding buy-back.

Commentary. PPK has generated negative operating and free cash flow in every year from FY22 to FY25, cumulatively about A$60m of FCF burn over four years. That burn was funded by subsidiary capital raisings (LIS IPO, WGL raises), asset sales and government grants. FY26's cash generation came almost entirely from realising CIB (A$27.2m) and CIB distributions (A$2.4m). Over its holding period, CIB returned A$9.4m in distributions plus A$27.7m (A$27.2m cash and A$0.5m deferred) in sale proceeds, against the A$5.0m invested in December 2019 — a 642% total return per the company.

Ratios

Notes:

  • All ratios are dossier calculations from reported figures. FY22 averages use FY21 closing balances (total assets A$96.602m; attributable equity A$76.648m).

ROIC: not meaningful, because operating income is not disclosed and earnings are dominated by non-operating gains.

Net debt/EBITDA: not meaningful, because group EBITDA is not disclosed and PPK is in net cash in four of five years.

Cash conversion cycle: not reliably computable, because trade payables are not separated from other payables in the excerpts reviewed. An indicative FY26 calculation (inventory 113 days + receivables about 47 days − payables about 201 days) gives a negative cycle, but the payables figure includes non-trade items. This should be treated as indicative only.

FY26 ROE and ROA: reflect one-off gains and are not representative of recurring returns.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityPPK interestAccountingActivityStatus

PowerPlus Energy Pty Ltd (incl. PPE Whispr Division Pty Ltd)

75.40%

Controlled subsidiary

LFP battery and BESS manufacturing (Melbourne)

Operating

Li-S Energy Limited (ASX: LIS)

39.11% (about 251m shares)

Associate (equity method)

Lithium-sulfur and lithium-metal cells; lithium foil

Pre-commercial / early revenue

White Graphene Limited (incl. BNNT Technology Pty Ltd)

39.36%

Associate (equity method)

Boron nitride nanosheets and nanotubes

Pre-revenue

PPK Investment Holdings Pty Ltd

100%

Subsidiary

Holds PPE convertible notes

—

BNNT Ballistics Pty Ltd

100%

Subsidiary

Former holder of the CIB stake

CIB sold 29 Jun 2026

PPK Plans 2 Pty Ltd

Trustee

Employee share trust

LTI administration

—

Craig International Ballistics Pty Ltd

0% (was 39.85%)

Associate until 29 Jun 2026

Ballistic protection

Divested

AMAG Holdings Australia Pty Ltd

0% (was 30%)

Associate until 16 Oct 2024

AI road-safety SaaS

Divested; earn-out

Segment revenue (AUD K)

Segment revenue (AUD K)FY23FY24FY25FY26

PowerPlus Energy sales revenue (AUD K)

5,08127,47122,99027,764

Consolidated revenue from contracts with customers (AUD K)

6,35228,18624,09228,709

CIB revenue, 100% basis, not consolidated (AUD K)

——48,100—

Results by Segment

Underlying PBT by segment (AUD K)FY24FY25FY26

PPE Energy Storage underlying PBT (AUD K)

-2,451-2,769424

WGL and BNNT nanomaterials underlying PBT incl. associate share (AUD K)

-4,153-2,532-1,696

LIS Energy underlying PBT incl. associate share (AUD K)

-3,919-3,465-1,900

CIB associate share of profit (AUD K)

1,8444,7182,799

AMAG associate share (AUD K)

-719-1930

Corporate underlying cost (AUD K)

-6,483-5,303-3,580

Total underlying PBT (AUD K)

-15,881-9,544-3,953

FY26 Item Details

FY26 item (AUD K)PPEWGL/BNNT disc.WGL/BNNT assoc.LISCIBCorporateTotal

Reported PBT

355,929-6884,95921,107-3,83327,509

Gain on deconsolidation

0-6,9370000-6,937

Gain on disposal of CIB

0000-18,3080-18,308

Amortisation of acquired intangibles

38900000389

Impairment reversal (LIS)

000-6,85900-6,859

Legal provision reversal

00000253253

Underlying PBT

424-1,008-688-1,9002,799-3,580-3,953

Income statement (AUD K)

Income statement (AUD K)FY22FY23FY24FY25FY26

Revenue from contracts with customers (AUD K)

1,6476,35228,18624,09228,709

Cost of sales (AUD K)

—-3,446-20,165-17,144-19,717

Gross profit (AUD K)

—2,9068,0216,9488,992

Share of associates profit/(loss) (AUD K)

-4,0391351,1252,781211

Finance costs (AUD K)

—-382-1,565-1,081-1,185

Profit/(loss) before tax, continuing ops (AUD K)

-7,024-12,643-13,326-30,82321,580

Income tax benefit/(expense), continuing (AUD K)

5037701,3543,696-7,555

Profit/(loss) after tax, continuing ops (AUD K)

-6,521-11,873-11,972-27,12714,025

Profit/(loss) after tax, discontinued ops (AUD K)

-6490-3,9191,4105,226

Net profit/(loss) after tax, total (AUD K)

-7,170-11,873-15,891-25,71719,251

Net profit/(loss) attributable to owners of PPK (AUD K)

-2,564-7,815-10,743-21,55319,213

Underlying PBT, non-IFRS (AUD K)

——-15,881-9,544-3,953

Basic EPS (A$ cents)

-2.9-8.8-12.1-23.821.2

Diluted EPS (A$ cents)

-2.9-8.8-12.1-23.820.4

Dividends per share, incl. in-specie (A$ cents)

2.81005.710

Capital return per share (A$ cents)

15.110000

Margins and growth (%)

Margins and growth (%)FY22FY23FY24FY25FY26

Gross margin (%)

—45.728.528.831.3

PBT margin, continuing (%)

-426.5-199.0-47.3-127.975.2

Net margin, total NPAT / revenue (%)

-435.3-186.9-56.4-106.767.1

Underlying PBT margin (%)

——-56.3-39.6-13.8

Revenue growth YoY (%)

—285.7343.7-14.519.2

Balance Sheet and Per-Share Data

Balance sheet (AUD K)FY22FY23FY24FY25FY26

Total assets (AUD K)

120,976135,580122,84673,60491,269

Cash and cash equivalents (AUD K)

53,00839,99928,3485,05827,674

Cash held directly by PPK parent (AUD K)

4,8103,8404,4563,56525,679

Borrowings, current (AUD K)

002,8345,2063,248

Borrowings, non-current (AUD K)

2,7563,346604555591

Total borrowings excl. leases (AUD K)

2,7563,3463,4385,7613,839

Lease liabilities, total (AUD K)

1,3006,3276,9724,1243,131

Net debt excl. leases, negative = net cash (AUD K)

-50,252-36,653-24,910703-23,835

Investments accounted for using equity method (AUD K)

10,7629,8149,23634,95538,731

Intangible assets and goodwill (AUD K)

37,47544,61744,7705,6573,708

Inventories (AUD K)

31312,0777,5187,4856,129

Total current assets (AUD K)

55,65857,92742,55521,59039,180

Total current liabilities (AUD K)

3,39718,05721,83124,19519,802

Working capital (AUD K)

52,26139,87020,724-2,60519,378

Total liabilities (AUD K)

8,39129,87028,92728,51429,417

Equity attributable to owners of PPK (AUD K)

81,51075,58167,74341,93261,893

Non-controlling interests (AUD K)

31,07530,12926,1763,158-41

Total equity (AUD K)

112,585105,71093,91945,09061,852

Net tangible assets per share, statutory (A$ cents)

81.8358.2943.7940.770.3

Cash flow (AUD K)

Cash flow (AUD K)FY22FY23FY24FY25FY26

Net cash from operating activities (AUD K)

-8,070-9,549-9,910-6,903—

Payments for property, plant and equipment (AUD K)

-2,929-3,468-6,202-1,581—

Payments for intangibles, capitalised development (AUD K)

-4,774-3,664-2,377-912—

Free cash flow, OCF minus PP&E and intangibles (AUD K)

-15,773-16,681-18,489-9,396—

Cash dividends paid by PPK (AUD K)

00000

In-specie dividends, non-cash (AUD K)

2,509005,1890

Share buy-backs (AUD K)

0027800

Proceeds from government grants for capital acquisitions (AUD K)

—03,592868—

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY22FY23FY24FY25FY26

ROE on avg attributable equity (%)

-3.2-9.9-15.0-39.337.0

ROA on avg total assets (%)

-6.6-9.3-12.3-26.223.4

Current ratio (x)

16.383.211.950.891.98

Debt to total equity, excl. leases (x)

0.0240.0320.0370.1280.062

Asset turnover, revenue / avg total assets (x)

0.0150.0500.2180.2450.348

Interest coverage, (PBT + finance cost) / finance cost (x)

—-32.1-7.5-27.519.2

Inventory days on cost of sales (days)

———159113

Geographic revenue (AUD K)

Geographic revenue (AUD K)FY24FY25FY26

Australia, consolidated revenue, company indicates domestic operations (AUD K)

28,18624,09228,709

Segment Overview

SegmentAustraliaInternational

PPE (consolidated)

All disclosed sales channels are Australian

None disclosed

LIS (associate, not consolidated)

Geelong manufacturing; Australian grant funding

US defence engagement (Paladin Defense Services as US representative; DEVCOM C5ISR delivery August 2026); UK (MSubs); New Zealand (Kea Aerospace)

WGL/BNNT (associate)

Geelong production

International distributors appointed FY26; samples to an international space agency and a European watchmaker

CIB (divested)

Gold Coast manufacturing; ADF customer

International interest cited; now owned by a German acquirer

Share price and TSR

Share price and TSRFY18FY19FY20FY21FY22FY23FY24FY25FY26

Share price at 30 June (AUD)

0.302.773.1115.952.041.380.380.3250.35

Annual shareholder return as reported (%)

5082313414-86-32-7218

Period Price Performance to 30 June 2026 Details

Period price performance to 30 June 2026Value

1-year (FY26) price change

+7.7% (A$0.325 to A$0.35); company-reported shareholder return 8%

3-year (FY23 end to FY26 end)

−74.6% (A$1.38 to A$0.35)

5-year (FY21 end to FY26 end)

−97.8% (A$15.95 to A$0.35)

52-week range (to July 2026)

A$0.29 – A$0.72 (StockAnalysis)

Recent trading

A$0.345 (17 July 2026); A$0.35–0.36 around the 6 August 2026 buy-back notice (InvestSMART).

Valuation Snapshot

MultipleValueComment

Market capitalisation

about A$31.7m

0.35 × 90.56m. Aggregators: A$31.2m (StockAnalysis, July 2026); A$36.7m (Simply Wall St, September 2026)

P/E (statutory FY26)

about 1.7x

Distorted by one-off gains; not meaningful

P/B (attributable equity A$61.9m)

about 0.51x

Book value per share about 68c

P/NTA (70.3c)

about 0.50x

Company view: material discount to underlying value

Enterprise value (dossier calculation)

about A$11.0m

Market cap A$31.7m + borrowings A$3.8m + leases A$3.1m − cash A$27.7m. Discrepancy: Eulerpool shows EV of A$40.52m (6 August 2026), apparently not netting the post-sale cash

EV/Sales

about 0.38x

On FY26 revenue of A$28.7m

Sum-of-parts reference points

Parent cash about A$25.7m (28.4c per share) + LIS stake at 12.5c × 251m ≈ A$31.4m (34.6c per share)

Before PPE, WGL, earn-outs, corporate costs and tax; illustrative only

Dividend history

Dividend historyFY20FY21FY22FY23FY24FY25FY26

Dividends per share (A$ cents)

2.03.52.81005.710

Analyst Conclusions

Management guidance

There is no quantitative guidance. Qualitatively, the Board:

  • expects to conclude a cornerstone acquisition within FY27;

  • will update shareholders at the 24 November 2026 AGM;

  • will run the buy-back of up to A$2.5m;

  • will keep supporting PPE's scale-up and associates; and

  • considers FY27 the start of its strongest strategic position to date (FY26 Chair's Report).

Consensus

There is no sell-side consensus (zero coverage).

Bull case

  1. Deep discount to tangible value. At about A$0.35 the shares trade at about 0.5x statutory NTA (70.3c). Parent cash alone is about 28c per share, and the LIS block at 30 June marks is about 35c per share. That implies negative value for PPE, WGL, the CIB earn-out (up to A$6.0m) and the AMAG earn-out.

  2. Capital-allocation credibility. The CIB exit (642% total return) shows the Board can buy, nurture and sell well. A disciplined cornerstone acquisition funded from about A$25m of cash, without dilution, could convert PPK from a discount-laden holding company into an earnings-based investment case.

  3. Operating and associate momentum. PPE has turned EBITDA-positive (A$1.3m), with ARENA-backed capacity tripling to 150 MWh. LIS's first US Army DEVCOM delivery and its A$7.8m ARENA scale-up grant create optionality on a 251m-share stake.

Bear case

  1. Earnings vacuum. With CIB gone, the underlying business is a near-breakeven PPE plus A$3.6m of corporate cost and equity-accounted losses from LIS and WGL. The underlying FY26 loss of A$4.0m included A$2.8m of CIB profit that will not recur.

  2. Execution and governance risk. A three-director board with no CEO is searching for a transformational acquisition in a competitive M&A market. The history of failed incubations (3D Dental, Precious Metals, Survivon, BNNT demand) argues for caution about capital deployment.

  3. Structural pressure on PPE and volatile associates. Import competition and CHBP-driven pricing compress margins. LIS valuation swings (an A$22.4m impairment followed by partial reversal) can repeatedly hit reported equity, and associates may need more capital.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhat to watch
2026 AGM acquisition update24 Nov 2026Target sector, size, valuation discipline, funding mix
Buy-back executionFY27Shares cancelled; average price versus NTA
H1 FY27 resultsLate Feb 2027PPE revenue and EBITDA run-rate; corporate cost; cash burn after CIB
PPE financingOngoing (Altus loan maturity 31 Aug 2026; notes Aug 2027)Refinancing or conversion; PPK support
PPE ARENA projectFY27Supplier contracts; commissioning; unit cost
CHBP program settingsOngoingRebate changes affecting residential pricing
LIS milestonesOngoingDEVCOM evaluation results; US orders; Phase 4 FEL-1 outcome; LIS share price (drives PPK impairment testing)
WGL commercial outcomesOngoingAny first supply agreement
CIB earn-outH1 FY28Milestone achievement (up to about A$6.0m)
Board / CEO appointmentsFY27Board depth; leadership arriving with an acquisition

Analyst verdict

PPK Group enters FY27 as a fundamentally different company from the one that peaked at A$15.95 a share in 2021. The technology-incubator thesis has largely been unwound. LIS and the nanomaterials business are deconsolidated minority stakes, the speculative application projects have been written off, and the group's best asset, Craig International Ballistics, has been sold for a 642% total return. What remains is A$27.7m of cash, a sub-scale but improving Australian battery manufacturer, a 39% block in a listed lithium-sulfur developer, a 39% stake in a pre-revenue nanomaterials company, and contingent earn-outs.

On paper the stock is cheap. It trades at roughly half of statutory NTA, and parent cash plus the LIS stake at 30 June marks exceed the market capitalisation. The Board's insider buying in April 2026 and its preference for a buy-back over a dividend signal that it shares that view.

The discount is not irrational, however. PPK has burned free cash flow in every disclosed year before FY26, its recurring earnings base is now negative without CIB, and its future depends on a single large decision — the cornerstone acquisition — to be taken by a three-person board without a chief executive. The company's history includes both outstanding (CIB) and poor (Survivon, BNNT applications, AMAG) capital-allocation outcomes, so the market is reasonably reserving judgement.

The investment case is therefore event-driven rather than earnings-driven. If the AGM update shows a disciplined, cash-generative Australian acquisition at a sensible multiple, the NTA discount should narrow materially. A dilutive, expensive or off-strategy deal would likely entrench it, as would continued drift. Absent sell-side coverage, the decisive monitorables are:

  • the November 2026 AGM disclosure;

  • PPE's H1 FY27 EBITDA run-rate;

  • PPE's refinancing; and

  • LIS's US defence validation results.

On balance the asset backing offers a margin of safety, but realising value requires execution the company has yet to demonstrate in its new form.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointed / tenureBackground and educationAgePPK shares held

Anne-Marie Birkill

Independent Non-Executive Chair; Chair of Nomination & Remuneration Committee; member of Audit & Risk Committee

Director since 1 July 2022; Chair since 1 July 2024

BSc (Hons), MBA, GAICD. Founding Partner and director of OneVentures (VC); NED of UniQuest (University of Queensland commercialisation company) and InterFinancial Corporate Finance; chairs the investment committee of the A$150m UQ-led Food and Beverage Accelerator; former CEO of i.lab incubator and GM of UniQuest

58 in 2022 (FY22 Annual Report); about 62 now

27,400

Glenn Molloy

Executive Director; member of Nomination & Remuneration Committee

Founder 1979; on the Board since listing (1994); Executive Director since September 2009

Founder of Plaspak; M&A and divestment adviser; director of PPE (and CIB until the sale)

67 in 2022; about 71 now

22,237,457 (about 24.6% of shares on issue)

Rick (Richard) Francis

Independent Non-Executive Director; Chair of Audit & Risk Committee; member of Nomination & Remuneration Committee

Since 2 December 2024

BCom, MBA, GAICD, CA. Former MD/CEO and earlier CFO of Spark Infrastructure (ASX 100); former NED of Victoria Power Networks and SA Power Networks; Deputy Chair of TransGrid; senior roles at APA and Origin Energy; NED of Li-S Energy (since 18 February 2025)

—

155,000 (bought in April 2026)

“—” = not publicly disclosed.

Executive Leadership Team

NameTitleSincePrior roles / education

Sarah Price

Chief Financial Officer (KMP)

Joined 28 March 2022; CFO from 23 May 2023

Not detailed in the reports reviewed

Will Shiel

General Counsel and Company Secretary

16 August 2021

BA (Hons) Law, FGIA; former Head of Legal (Technology) at ASX Limited; Allens Linklaters, Gilbert+Tobin, Clifford Chance

Liam Fairhall

Deputy General Counsel and Company Secretary

30 June 2022

BLaw (Hons), BMed Rad Sci, Grad Dip ACGRM; former Head of Legal/CoSec at a payments-focused bank

Group CEO

Vacant

Since 5 December 2025

The Board says a standalone CEO is not currently required and that an acquired business may bring a future Group leader (FY26 Chair's Report)

Directors' Remuneration

KMPCash salary and feesCash bonusSuperannuationShare-basedTotal FY26Total FY25

Anne-Marie Birkill (Chair)

100,000000100,000100,000

Rick Francis (NED)

170,089020,4110190,50042,500

Glenn Molloy (Exec. Director)

227,500000227,500212,500

Marc Fenton (MD/CEO, to 5 Dec 2025)

217,21897,52015,0000329,738653,058

Sarah Price (CFO)

300,00186,67030,000156,418573,089534,957

Total KMP

1,014,808184,19065,411156,4181,420,8271,566,348

Board & Management Changes

DateChangeContext

1 Jul 2024

Birkill becomes Chair; Fenton becomes MD

Board restructure after Levison's announced retirement

31 Aug 2024

Levison retires

Chair since 2013 (executive and non-executive periods)

2 Dec 2024

Francis appointed

Outcome of an external search for energy-sector experience

6 Jun 2025

Fenton resigns (six-month notice)

Rights assessed as good leaver; partial forfeiture

5 Dec 2025

Fenton departs; CEO role not replaced

Board considers a standalone CEO unnecessary at current scale

Major Shareholders

HolderSharesApprox. % of ~90.56mSource

Glenn Molloy and related parties

22,237,45724.6

FY26 Annual Report

Sarah Price (CFO)

378,9960.4

FY26 Annual Report

Rick Francis

155,0000.2

FY26 Annual Report

Anne-Marie Birkill

27,4000.03

FY26 Annual Report

Employee share trusts

90,000 (FY26 report); 468,344 (FY25 report date)

0.1–0.5

Annual Reports

Total KMP holdings

22,798,853

about 25.2

FY26 Annual Report

Competitive Landscape

Competitors by Segment

SegmentCompetitorTypeRelative positioning vs PPK portfolio

Stationary storage (PPE)

Tesla (Powerwall)

Global OEM

Dominant residential brand; far larger scale and lower cost

Stationary storage (PPE)

BYD (Battery-Box)

Global cell and system maker

Vertically integrated cells; strong in rack-mount LFP

Stationary storage (PPE)

Sungrow

Global inverter and ESS

Integrated inverter and battery

Stationary storage (PPE)

Alpha ESS

Chinese ESS supplier

Aggressive pricing in the Australian residential market

Stationary storage (PPE)

SolaX Power

Chinese inverter and battery

Price competitor

Stationary storage (PPE)

Redback Technologies

Australian (Brisbane) hybrid inverter/battery

Local brand competitor (not to be confused with Redx, a PPE partner)

Stationary storage (PPE)

Zenaji

Australian LFP/LTO battery brand

Direct "Australian" positioning competitor

Stationary storage (PPE)

Energy Renaissance

Australian cell and battery manufacturer (NSW)

Sovereign-manufacturing peer

Stationary storage (PPE)

Enphase (IQ Battery)

Global microinverter and battery

Premium residential

Lithium-sulfur (LIS)

Lyten (US)

Li-S developer

Larger funded US competitor

Lithium-sulfur (LIS)

Zeta Energy (US)

Li-S developer (LIS has held an investment)

Peer and partner

Lithium-sulfur (LIS)

Theion (Germany)

Li-S developer

European peer

Lithium-sulfur (LIS)

Gelion (ASX: GN1)

Li-S and zinc battery developer

ASX-listed peer

BNNT (WGL)

BNNT LLC (US); Tekna (Canada); BNNano (US)

BNNT producers

Peers in a nascent market with no material volume sales globally (company view)

Ballistics (former CIB)

Point Blank, Ceradyne, other armour makers

Global armour suppliers

No longer relevant after the sale

Competitor Detail

MetricPPK Group (consolidated)

Revenue

A$28.7m (FY26)

Revenue growth

+19.2% (FY26)

Gross margin

31.3% (FY26)

R&D intensity

Not disclosed (proxy nil consolidated in FY26)

Recent Developments

Headcount reductions occurred implicitly through the deconsolidations.

Company Snapshot

1979

Founded

Brisbane, Australia

Headquarters

SWOT Analysis

Strengths

  • Liquidity reset: A$27.7m of consolidated cash at 30 June 2026 (A$25.7m held by the parent), up from A$5.1m a year earlier (FY26 Annual Report).
  • Proven value-realisation record: CIB returned 642% in total (including A$9.4m of distributions) on a A$5.0m investment made in December 2019 (FY26 Annual Report).
  • PPE turnaround: revenue up 21% to A$27.8m, EBITDA of A$1.3m, and loss before tax narrowed from A$3.2m to A$0.3m in FY26.
  • Asset backing well above the share price: statutory NTA of 70.3c per share against a share price of about A$0.35 (FY26); adjusted NTA is 64.7c.
  • Simplified structure: LIS and WGL deconsolidated, AMAG and CIB sold, giving fewer related-party conflicts (FY26 ESG Report).
  • Grant-funded growth: A$2.3m ARENA grant to PPE; A$7.8m ARENA and A$1.7m IGP grants to LIS.
  • Aligned founder: Glenn Molloy holds about 24.6%; independent directors bought on market in April 2026.

Weaknesses

  • No recurring profitability at group level: underlying PBT of A$(4.0)m in FY26 and negative in every year disclosed.
  • Persistent cash burn: operating cash flow negative in FY22–FY25 (between A$(6.9)m and A$(9.9)m a year).
  • Loss of the best earner: CIB contributed A$2.8m–A$4.7m of underlying profit, which disappears from FY27.
  • No Group CEO: a thin three-person board leads a transformational acquisition process.
  • Single-business revenue concentration: PPE accounts for about 97% of revenue, with an EBITDA margin of about 4.7%.
  • Reporting complexity: repeated re-presentations and non-IFRS reliance (re-presented FY24 and FY25 comparatives).
  • Nanomaterials failure to commercialise: BNNT and white graphene produced no material revenue; projects including 3D Dental, Precious Metals and Ballistic Glass were halted.

Opportunities

  • Cornerstone acquisition: about A$25m of deployable capital to buy an Australian business outright, potentially in energy storage consolidation.
  • CIB earn-out: up to about A$6.0m, determined in H1 FY28 and not recognised in the accounts.
  • LIS re-rating: the US Army DEVCOM delivery and Phase 4 feasibility; the 251m-share block was marked at 12.5c (about A$31.4m) at 30 June 2026.
  • PPE capacity expansion: to 150 MWh per year with semi-automation, lowering unit cost.
  • Lead-acid replacement: utilities and telco demand (LiNET4835) outside the rebate program.
  • Buy-back accretion: up to A$2.5m of buy-backs at a roughly 50% discount to NTA.
  • AMAG earn-out: uncapped, though highly uncertain.

Threats

  • Import price competition: low-cost imports and rebate-driven price compression in residential storage (FY26 Annual Report).
  • Policy risk: changes to the CHBP have already altered market dynamics during FY26.
  • LIS share-price volatility: this drives mark-to-market impairments (A$22.4m in FY25, partial reversal in FY26) under AASB 13 Level 1 valuation.
  • Associate funding needs: associates may need further capital, risking dilution or calls on PPK cash (FY26 material business risks).
  • Acquisition execution risk: overpaying or integration failure in a transformational deal.
  • Cyber and IP risk: cyber breach and IP loss are identified material risks.
  • Concentration in a related-party-financed subsidiary: PPE debt includes notes held by Molloy entities and a minority-shareholder loan.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
6 Jun 2025CEO/MD Marc Fenton gives six months' notice of resignationLeadership transition begins
1 Jul 2025Federal Cheaper Home Batteries Program goes live; PPE's Eco4847P and Whispr-7 are CEC approved and eligibleDemand catalyst for PPE
Jul 2025PPK discloses an unsolicited, non-binding indicative offer for its CIB stake; due diligence followed but no deal was concludedValidated CIB value; precursor to the 2026 sale
Jul 2025PPE July 2025 sales up about 40% on July 2024Early CHBP uplift
10 Jul 2025WGL acquires 100% of BNNT Technology for scripNanomaterials consolidation
18 Jul 2025CIB pays a A$2.4m dividend to PPKCash to parent at a tight moment
25 Aug 2025PPK extends a A$2.0m loan from LIS to October 2026Liquidity management; FY25 going-concern context
29 Aug 2025FY25 results: attributable loss of A$21.6m; LIS impairment of A$22.4m; underlying loss of A$9.5mLow point of reported earnings
3 Oct 2025FY25 Annual Report lodged (dated 29 August 2025)—
5 Nov 2025WGL deconsolidated after a 22.5m share sale; A$6.9m gainSimplification
13 Nov 2025FY26 performance rights (460,358) granted to the CFORemuneration
26 Nov 2025Virtual AGM; remuneration report passes with 95.87%Governance
5 Dec 2025Fenton departs; CEO role not refilledBoard-led executive model
19 Dec 2025Final settlement of a NSW Supreme Court dispute dating from a 2014 acquisition; A$747k paid toward claimant costs; A$253k provision reversedLitigation closed
5 Feb 2026PPE stake increased to 75.4%Consolidated control of PPE
24 Feb 2026Altus Construction loan to PPE extended to 31 August 2026; PPK loan terms with WGL and PPE extendedLiquidity
27 Feb 2026H1 FY26 results: attributable profit of A$10.5m; PPE H1 revenue up 32% to A$15.7mTurnaround in reported earnings
Mar 2026 qtrLIS receives the first A$1.9m tranche of its A$7.8m ARENA grant; appoints HatchAssociate scale-up pathway
Apr 2026PPE awarded A$2.3m from ARENA's Battery Breakthrough InitiativeManufacturing scale-up
20 Apr 2026Binding conditional SPA to sell the CIB stake to Mehler (up to A$33.43m); shares rise about 20% on the day (InvestSMART)Transformational realisation
20–28 Apr 2026Directors buy on market: Birkill 10,000 shares at A$0.37; Francis 85,000 at A$0.379 and 70,000 at A$0.385Insider confidence signal
May 2026Employee share trust buys 120,507 shares at A$0.33LTI settlement
29 Jun 2026CIB SPA unconditional; completion with A$27.2m cash receivedBalance sheet reset
6 Aug 2026Buy-back notification lodged (up to A$2.5m)Capital return
24 Aug 2026LIS delivers its first Li-S cells to the US Army DEVCOM C5ISR CenterKey associate milestone
27 Aug 2026FY26 results: attributable NPAT of A$19.2m; underlying loss of A$(4.0)m; NTA 70.3cStatutory profit driven by one-offs
31 Aug 2026Buy-back expected to commenceSupports share price
2 Oct 2026Director nominations close for the 2026 AGMGovernance
24 Nov 2026 (upcoming)Virtual AGM; Chair has promised an update on the acquisition searchKey catalyst

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Revenue from contracts with customers rose from AUD 1.6 Mn in FY2022 to AUD 28.7 Mn in FY2026.
PPK Group Limited — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2022FY2023FY2024FY2025FY2026
Revenue from contracts with customers1.66.428.224.128.7
Cost of sales—-3.4-20.2-17.1-19.7
Gross profit—2.986.99

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.